Low-dose IL-2 as a therapeutic agent for tolerance induction

Immunotherapy. 2011 Nov;3(11):1281-4. doi: 10.2217/imt.11.120.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Animals
  • Clinical Trials as Topic
  • Diabetes Mellitus, Type 1 / immunology
  • Diabetes Mellitus, Type 1 / therapy*
  • Humans
  • Immune Tolerance / drug effects*
  • Immunotherapy / methods*
  • Interleukin-2 / administration & dosage*
  • Interleukin-2 / adverse effects
  • Mice
  • Mice, Inbred C57BL
  • T-Lymphocytes, Regulatory / immunology*

Substances

  • Interleukin-2